FDA Lifts Major Warnings on Hormone Replacement Therapy
- * FDA lifts Warnings: The Food and Drug Administration (FDA) has removed broad "black box" warnings from hormone replacement therapy (HRT).
Here’s a breakdown of the key data from the provided text:
* FDA lifts Warnings: The Food and Drug Administration (FDA) has removed broad “black box” warnings from hormone replacement therapy (HRT).
* Alternatives Exist: Dr. Stephanie Faubion, of the Center for Midlife Health and Menopause at NYU Langone Health, notes that alternatives to HRT include cognitive therapy and non-hormonal medications.
* Risk Information Remains: While the broad warnings are gone, detailed information about specific risks will still be included in the package inserts for HRT.
* Further Resources: The American College of Obstetricians and Gynecologists (ACOG) provides resources and guidelines on menopausal hormone therapy: https://www.acog.org/womens-health/faqs/hormone-therapy-for-menopause
* Source & Date: The information comes from HealthDay, published November 15, 2025.